Drug Efficacy, Safety, and Biologics Discovery
Emerging Technologies and Tools
Normal Price: $212.95
Your Price: $191.66 AUD, inc. GST
Shipping: $7.95 per order
You Save: $21.29! (10% off normal price)
Plus...earn $9.58 in Boomerang Bucks
Availability: Available to Backorder, No Due Date for Supply, Not for Xmas
Drug Efficacy, Safety, and Biologics Discovery by Sean Ekins
Book DescriptionDrug Efficacy, Safety, and Biologics Discovery: Emerging Technologies and Tools covers key emerging technologies in pharmaceutical R & D and how they have substantially impacted (or are currently impacting) drug discovery. The cross-disciplinary collaborations implicit in integrating these technologies with drug discovery operations will fuel the engine for future innovations. This book cuts across the multiple areas of drug discovery, each chapter authored by pioneers in that field, making for a broad appeal to the chemical and biological scientists and technologists involved in drug discovery and development.
Buy Drug Efficacy, Safety, and Biologics Discovery book by Sean Ekins from Australia's Online Bookstore, Boomerang Books.
Book DetailsISBN: 9780470225554
(244mm x 165mm x 25mm)
Publisher: John Wiley and Sons Ltd
Publish Date: 27-Jan-2009
Country of Publication: United States
Books By Author Sean Ekins
Collaborative Computational Technologies for Biomedical Research, Hardback (July 2011)
Covering a neglected but important topic of management and information technology collaborations in drug discovery and development, this book discusses the state-of-the-art collaborative and computing techniques for the pharmaceutical industry.
Pharmaceutical and Biomedical Project Management in a Changing Global Environment, Hardback (August 2010)
This book explores many critical forces at work today in pharmaceutical and medical product development. Applying a structured project management framework enables companies to select and allocate the appropriate people and resources to achieve success.
Agile Approach to Adaptive Research, Hardback (March 2010)
This book helps pharmaceutical and medical researchers better understand, design, and manage clinical trials through its industry-specific viewpoint that shows how adaptive research technology and methods benefit the drug industry.
Pharmaceutical Data Mining, Hardback (January 2010)» View all books by Sean Ekins
Extracting and applying knowledge from chemical, biological, and clinical data is one of the biggest problems for the pharmaceutical industry.
» Have you read this book? We'd like to know what you think about it - write a review about Drug Efficacy, Safety, and Biologics Discovery book by Sean Ekins and you'll earn 50c in Boomerang Bucks loyalty dollars (you must be a member - it's free to sign up!)
Author Biography - Sean Ekins
Sean Ekins, MSc, PHD, DSc, is the Principal at Collaborations in Chemistry; and Adjunct Associate Professor in the Department of Pharmaceutical Sciences at the University of Maryland, School of Pharmacy. Dr. Ekins has published widely on ADME/Tox, systems biology, computational, and in vitro drug discovery approaches. He has previously edited two Wiley books: Computer Applications in Pharmaceutical Research and Development (2006) and Computational Toxicology: Risk Assessment for Pharmaceutical and Environmental Chemicals (2007). Jinghai J. Xu, PHD, is Director of Automated Biotechnology at Merck. Previously he headed predictive toxicology at Pfizer, where he led research activities in drug-induced liver injury, genetic toxicology, drug transporters, assay development, high content screening, in vitro in vivo correlations, systems biology, and systems toxicology. Dr. Xu has served on steering committees of academic-industry and industry-industry collaborations, and as a guest lecturer at the Massachusetts Institute of Technology.
Phone: 1300 36 33 32 (9am-2pm Mon-Fri AEST) - International: +61 2 9960 7998 - Online Form
Address: Boomerang Books, 878 Military Road, Mosman Junction, NSW, 2088
© 2003-2016. All Rights Reserved. Eclipse Commerce Pty Ltd - ACN: 122 110 687 - ABN: 49 122 110 687